Melanoma in situ of the unspecified upper limb, including the shoulder, is a localized skin cancer characterized by the uncontrolled growth of melanocytes. This condition is clinically significant as it can progress to invasive melanoma if not detected and treated early. The ICD-10 Code D03.60 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and track this condition.
ICD-10 Code D03.60 represents melanoma in situ located in the unspecified upper limb, including the shoulder. This code is used when a patient presents with a localized melanoma that has not invaded deeper tissues. It is essential for clinical documentation and billing when diagnosing patients with this specific type of skin cancer, ensuring appropriate treatment and follow-up.
Melanoma in situ of the unspecified upper limb, including the shoulder, is primarily caused by ultraviolet (UV) radiation exposure, leading to genetic mutations in skin cells. This condition requires prompt medical attention to prevent progression to invasive melanoma. Early detection and treatment are crucial for favorable outcomes.
ICD-10 Code D03.60 is utilized in SOAP notes to document the presence of melanoma in situ in the upper limb, including the shoulder. This code aids in capturing the patient's symptoms, assessment findings, and treatment plans, ensuring comprehensive documentation in both acute and chronic care settings.
In SOAP notes, ICD-10 Code D03.60 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of melanoma in situ. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Prompt treatment of melanoma in situ is essential to prevent progression. Surgical excision is the primary treatment approach.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D03.60 is critical in medical billing, particularly in hospital, ER, or oncology settings.
| CPT Code | Description |
|---|---|
| 11600 | Excision, malignant skin lesion, face, ears, scalp, neck; excised diameter excised 0.5 cm or less. |
| 11601 | Excision, malignant skin lesion, face, ears, scalp, neck; excised diameter excised 0.6 to 1.0 cm. |
| 99213 | Established patient office visit, level 3. |
Common Questions About Using ICD-10 Code D03.60 for Melanoma in situ of unsp upper limb, including shoulder
What are the risk factors for melanoma in situ?
Risk factors include excessive UV exposure, a history of sunburns, having many moles, and a family history of skin cancer. Regular skin checks are essential for early detection.
How is melanoma in situ treated?
Melanoma in situ is primarily treated through surgical excision of the lesion. Follow-up care is crucial to monitor for any new lesions or changes.
Is melanoma in situ contagious?
No, melanoma in situ is not contagious. It is a type of skin cancer that arises from genetic mutations in skin cells, not from infectious agents.
How often should patients with melanoma in situ have follow-up appointments?
Patients should have follow-up appointments every 3 to 6 months for the first few years after treatment, then annually, to monitor for recurrence or new skin cancers.
Clinical Notes
SOAP notes
DAP notes
AI medical notes